Spartan Planning & Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Sell
5,209
-358
-6% -$83.4K 0.88% 28
2026
Q1
$1.36M Buy
5,567
+741
+15% +$173K 1.01% 21
2025
Q4
$999K Buy
4,826
+198
+4% +$39.2K 0.74% 26
2025
Q3
$858K Buy
+4,628
New +$793K 0.67% 30
2025
Q2
Sell
-4,088
Closed -$678K 82
2025
Q1
$678K Buy
+4,088
New +$640K 0.66% 34
2022
Q4
$278K Buy
+1,575
New +$272K 0.35% 47
2022
Q3
Sell
-2,199
Closed -$390K 96
2022
Q2
$390K Buy
2,199
+817
+59% +$146K 0.52% 22
2022
Q1
$245K Buy
+1,382
New +$235K 0.31% 45

Other funds holding JNJ

Spartan Planning & Wealth Management's JNJ Position: Q2 2026 in Review

Spartan Planning & Wealth Management reduced its Johnson & Johnson (JNJ) stake by 6.4% in Q2 2026, selling an estimated $83.4K and leaving 5,209 shares worth $1.32M. The position accounts for 0.88% of the portfolio, ranked #28.

Spartan Planning & Wealth Management first reported a position in JNJ in Q1 2022 and has held it in 8 quarters since. The position peaked at $1.36M in Q1 2026. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Spartan Planning & Wealth Management held 5,209 shares of Johnson & Johnson worth $1.32M as of Q2 2026.
  • Spartan Planning & Wealth Management sold 358 Johnson & Johnson shares in Q2 2026, an estimated $83.4K.
  • Johnson & Johnson made up 0.88% of Spartan Planning & Wealth Management's portfolio in Q2 2026, its #28 holding.
  • Spartan Planning & Wealth Management first reported a position in Johnson & Johnson in Q1 2022 and has held it in 8 quarters since.
  • Spartan Planning & Wealth Management's Johnson & Johnson position peaked at $1.36M in Q1 2026.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Spartan Planning & Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.